Vaccines

22 Jun 2009 Positive Phase I Trial Results for Pevion Biotech’s and Bio Life Science’s Breast Cancer Vaccine
19 Jun 2009 Avir Green Hills: Excellent Preclinical Data on Novel Type of Intranasal H5N1 Influenza Vaccine
19 Jun 2009 Lytix Biopharma and KAEL-GemVax Announce Joint Clinical Trial to Combine LTX-315 and GV1001 Cancer Immunotherapy
17 Jun 2009 Antigenics' QS-21 Adjuvant Enters Pivotal Phase 3 Clinical Trial of GlaxoSmithKline's Malaria Vaccine
17 Jun 2009 VaxInnate Reports Positive Results from Preclinical Testing of Swine Flu Vaccine Developed Using Novel Technology
15 Jun 2009 Advaxis Clinical Trial Survival Data Significantly Exceeds the National Cancer Institute's Median Survival Statistic
15 Jun 2009 Baxter Advances to Full-Scale Production of A/H1N1 Vaccine
12 Jun 2009 Novartis successfully demonstrates capabilities of cell-based technology for production of A(H1N1) vaccine
11 Jun 2009 New Phase 3 Data Continue to Indicate that Wyeths Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
11 Jun 2009 Genetic Immunity, InPlay: Company Completes Patient Enrollment in Phase II Trial of DermaVir Patch HIV Immunotherapeutic Nanomedicine Lead Product Candidate
11 Jun 2009 Cytos Biotechnology initiates combined phase I/IIa study with a novel anti-interleukin-1 beta vaccine in patients with type II diabetes mellitus
10 Jun 2009 Bayhill Therapeutics Enters Exclusive, Worldwide Collaboration with Genentech for BHT-3021 in Type 1 Diabetes
04 Jun 2009 Novartis announces typhoid vaccine research program in partnership with the Wellcome Trust
04 Jun 2009 Apthera Announces Product License Agreement With Kwang Dong Pharmaceutical Co., Ltd.
04 Jun 2009 ImmunoCellular Therapeutics Reports Additional Data from Promising Brain Cancer Clinical Trial
04 Jun 2009 ImmunoCellular Therapeutics Reports Additional Data from Promising Brain Cancer Clinical Trial
03 Jun 2009 Nabi Biopharmaceuticals Receives Scientific Advice On NicVAX(r) From the European Medicines Agency
31 May 2009 Positive, Clinically Significant Phase III Results for Personalized Anti-Cancer Vaccine, BiovaxID®, Presented at ASCO Plenary Session
29 May 2009 Intercell AG Announces First Subject Enrolled in a Phase II Trial for the further development of its investigational Vaccine Enhancement Patch to improve Pandemic Influenza prevention in Collaboration with U.S. Department of Health and Human Services (HHS
27 May 2009 AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
26 May 2009 Takeda to License Vaccine for Haemophilus Influrnzae Type B from Novartis
26 May 2009 Vaxart Begins Animal Testing of H1N1 Flu Vaccine Candidate
26 May 2009 Senesco Announces H1N1 Influenza Survival Test Results in Mice
26 May 2009 ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine
25 May 2009 Bioniche Phase III Clinical Trial with Urocidin™ Progressing Well

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top